Prospects for prostatic cancer incidence and treatment by the year 2000

International Journal of Andrology

Volumn 19, Issue 1, 1996, Pages 1-10

  Forti, G ^a,b   Selli, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Andrology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BICALUTAMIDE; CADMIUM; CYPROTERONE ACETATE; FINASTERIDE; FLUTAMIDE; GONADORELIN DERIVATIVE; NILUTAMIDE; OXIDOREDUCTASE; PESTICIDE; TESTOSTERONE;

AGING; BEAM THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; DEMOGRAPHY; DIET; FAT INTAKE; HEALTH CARE COST; HUMAN; LIFESTYLE; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; ORCHIECTOMY; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK FACTOR; VASECTOMY; VISUAL DISORDER;

EID: 0029965396     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2605.1996.tb00426.x     Document Type: Review

References (82)

1. Adolfsson, J., Ronstrom, L., Lowhagen, T., Carstensen, J. & Hedlund, P. O. (1994) Deferred treatment of clinically localized low-grade prostate cancer: the experience from a prospective series at the Karolinska Hospital. Journal of Urology, 152, 1757-1760.
2. Adolfsson, J., Steineck, G. & Whitmore, W. E. Jr (1993) Recent results of management of palpable clinically localized prostate cancer. Cancer, 72, 310-322.
3. Alexander, N. J., Free, M. J., Paulson, C. A., Buschbom, R. & Fulgham, D. L. (1980) A comparison of blood chemistry, reproductive hormones, and the development of antisperm antibodies after vasectomy in men. Journal of Andrology, 1, 40-50.
4. Beck, J. B., Kattan, M. W. & Miles, B. J. (1994). A critique of the decision analysis for clinically localized prostate cancel. Journal of Urology, 152, 1894-1899.
5. Bischoff, F. (1969) Carcinogenic effects of steroids. Advances in Lipid Research, 7, 165-244.
6. Blair, A. & Zahm, S. H. (1991) Cancer among farmers. Occupational Medicine, 6, 335-354.
7. Brawley, O. W., Ford, L. G., Thompson, I., Perlman, J. A. & Kramer, B. S. (1994) 5α-reductase inhibition and prostate cancer prevention. Cancer Epidemiology Biomarkers Prevention, 3, 177-182.
8. Brinkmann, A. O., Jenster, G., Ris-Stalpers, C., van der Korput, J. A. G. M., Bruggenwirth, H. T., Boehmer, A. L. M. & Trapman, J. (1994) Androgen receptor abnormalities. In: Sex Hormones and Antihormones in Endocrine Dependent Pathology: basic and clinical aspects (eds M. Motta and M. Serio) pp. 33-44. Elsevier Science B., Amsterdam.
9. Brothman, A. D., Peehl, D. M., Patel, A. M. & McNeal, J. E. (1990) Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Research, 50, 3795-3803.
10. Cannon, L., Bishop, D., Skolnick, M., Hunt, S., Lyon, J. & Smart, C. (1982) Genetic epidemiology of prostate cancer in Utah Mormon genealogy. Cancer Survey, 1, 47-69.
11. Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B. & Walsh, P C. (1992) Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences, USA, 89, 3367-3371.
12. Carter, H. B. & Coffey, D. S. (1990) The prostate: an increasing medical problem. Prostate, 16, 39-48.
13. Catalona, W. S., Smith, D. S., Ratliff, T. L. & Basler, J. W (1993) Detection of organ-confined prostatic cancer is increased through prostate-specific antigen based screening. Journal of the American Medical Association, 270, 948-954.
14. Chadwick, D. J., Gillatt, D. A. & Gingell, J. C. (1991) Medical or surgical orchiectomy: the patient's choice. British Medical Journal, 302, 571-578.
15. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W, Chisholm, G. D., Moskowitz, B., Liung, P. M. & Warner, J. (1994) Results of conservative management of clinically localized prostate cancer. New England Journal of Medicine, 330, 242-248.
16. Coetzee, G. A. & Ross, R. K. (1994) Prostate cancer and the androgen receptor. Journal of the National Cancer Institute, 86, 872-873.
17. De Carli, A., La Vecchia, C., Negri, E. & Cislaghi, C. (1993) Cancer mortality in Italy, 1989, and an overview of trends from 1955 to 1989. Tumori, 79, 151-165.
18. De La Torre, B., Hedman, M., Jensen, F., Pedersen, P. H. & Dicfalusy, E. (1983) Lack of effects of vasectomy on peripheral gonadotropin and steroid levels. International Journal of Andrology, 6, 125-134.
19. Delzell, E. & Monson, R. R. (1982) Mortality among rubber workers. V Processing workers. Journal of Occupational Medicine, 24, 539-545.
20. Dillioglugil, O., Miles, B. J. & Scardino, P. T. (1995) Current controversies in the management of localized prostate cancer. European Urology, 28, 85-101.
21. Doll, R. & Peto, R. (1981) The causes of cancer. Journal of the National Cancer Institute, 66, 1191-1308.
22. Dupont, J., White, P. J. & Feldman, E. B. (1991) Saturated and hydrogenated fats in food in relation to health. Journal of the American College of Nutrition, 10, 577-592.
23. Fincham, S. M., Hill, G. B., Hanson, J. & Wijayasinghe, C. (1990) Epidemiology of prostatic cancer: a case - control study. Prostate, 17, 189-206.
24. Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J. & Wennberg, J. E. (1993) A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Journal of the American Medical Association, 269, 2650-2658.
25. Frehia, F. S. & Bagshaw, M. A. (1984) Carcinoma of the prostate: results of post-irradiation biopsy. Prostate, 5, 19-24.
26. Gann, P H., Hennekens, C. H., Sacks, F. M., Grodstein, P., Giovannucci, E. & Stampfer, M. J.(1994) A prospective study of plasma fatty acids and risk of prostate cancer. Journal of the National Cancer Institute, 86, 281-286.
27. Geary, E. S., Dendinger, T. E., Frehia, F. S. & Stamey, T. A. (1995) Nerve sparing radical prostatectomy: a different view. Journal of Urology, 154, 145-149.
28. Giovannucci, E. (1995) Epidemiologic characteristics of prostate cancer. Cancer, 75, 1766-1777.
29. Goldsmith, D. F., Smith, A. H & McMichael, A. J.(1980) A case - control study of prostate cancer within a cohort of rubber and tire workers. Journal of Occupational Medicine, 22, 533-541.
30. Haenszel, W. & Kurihara, M. (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. Journal of the National Cancer Institute, 40, 43-68.
31. Hanchette, C. L. & Schwartz, G. G. (1992) Geographic patterns of prostate cancer mortality. Cancer, 70, 2861-2869.
32. Hill, P, Wynder, E. L., Garbaczweski, L., Garnes, H. & Walker, A. R. (1979) Diet and urinary steroids in black and white North American men and black South African men. Cancer Research, 39, 5101-5105.
33. Hsing, A. & Comstock, G. (1989). Serum hormones and risk of subsequent prostate cancer. American Journal of Epidemiology, 130, 829-834.
34. Huggins, C. & Hodges, C. V. (1941) Studies on prostatic cancer. The effect of castration, of estrogen and androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1, 293-297.
35. Jouannet, P. & David, G. (1978) Evolution of the properties of semen immediately following vasectomy. Fertility and Sterility, 29, 435-441.
36. Krahn, M. D., Mahoney, J. E., Eckman, M. H., Trachtenberg, J., Pauker, S. G. & Detsky, A. S. (1994) Screening for prostate cancer: a decision analytic view. Journal of the American Medical Association, 272, 773-780.
37. Labrie, F., Dupont, A. & Belanger, A. (1983) New approach in the treatment of prostatic cancer. Complete instead of partial withdrawal of androgens. Prostate, 4, 579-594.
38. Lu-Yao, G. L., McLerran, D., Wasson, & Wennberg, J. E. (1993) An assessement of radical prostatectomy: time trends, geographic variation and outcomes. Journal of the American Medical Association, 269, 2633-2636.
39. McClinton, S., Moffat, L. E. F. & Lubrook, A. (1989) The cost of bilateral orchiectomy as a treatment for prostatic carcinoma. British Journal of Urology, 63, 309-312.
40. McMichael, A. J., Spirtas, R., Gamble, J. F. & Tousey, P. M. (1976) Mortality among rubber workers: relationship to specific jobs. Journal of Occupational Medicine, 18, 178-185.
41. Meikle, A. A. W. & Stanish, W. M. (1982) Familial prostatic cancer risk and low testosterone. Journal of Clinical Endocrinology and Metabolism, 54, 1104-1108.
42. Mettlin, C. (1995) American Cancer Society National Prostate Cancer Detection Project: goals and current status. Cancer, 75, 1790-1794.
43. Mettlin, C., Murphy, G. P., Lee, F., Littrup, P. J., Chesley, A., Babaian, R., Badalament, R., Krane, R. A. & Mostofi, F. K. (1993) Characteristics of prostate cancer detected in multimodality early detection program. Cancer, 72, 1701-1708.
44. Moller Jensen, O. M., Estève, J., Moller, H. & Renard, H. (1990) Cancer in the European Community and its member states. European Journal of Cancer, 26, 1167-1256.
45. Morrison, H., Savitz, D., Semenciw, R., Hulka, B., Mao, Y, & Morison, D. & Wigle, D. (1993) Farming and prostate cancer mortality. American Journal of Epidemiology, 137, 270-280.
46. Moul, J. W., Srivastavas, V. & McLeod, D. G (1995) Molecular implications of the antiandrogen withdrawal syndrome. Seminars in Urology, 13, 157-163.
47. Muir, C., Waterhouse, J., Mack, T., Powell, J. & Whelan, S. (eds) (1987) Cancer Incidence in Five Continents, Vol. V. Lyon: IARC Science Publication no. 88.
48. Murphy, G. P., Natarajan, N., Pontes, J. E., Schmitz, R. L., Smart, C. R., Schmidt, J. D. & Mettlin, C. (1982) The national survey of prostate cancer in the United States by the American College of Surgeons. Journal of Urology, 127, 928-933.
49. Naik, Y K., Joshi, U. M. & Sheth, A. R. (1980) Long-term effects of vasectomy on prostatic function in men. Journal of Reproduction and Fertility, 58, 289-293.
50. Nomura, A., Heilbrun, L. K., Stemmerman, G. N. & Judd, H. L. (1988) Prediagnostic serum hormones and the risk of prostatic cancer. Cancer Research, 48, 3515-3517.
51. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. & Scardino, P. T. (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? Journal of Urology, 152, 1843-1849.
52. Oishi, K., Okada, K., Yoshida, O., Yamabe, H., Ohno, Y, Hayes, R. B & Schroeder, F. (1989) Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors. Prostate, 14, 117-122.
53. Optenherg, S. A. & Thompson, I. M. (1990) Economics of screening for carcinoma of the prostate. Urological Clinics of North America, 17, 719-737.
54. Parkin, D. M., Pisani, P. & Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer, 54, 594-596.
55. Partin, A. W., Puond, C. R., Clemens, J. Q., Epstein, J. I. & Walsh, P C. (1993) Serum PSA after anatomical radical prostatectomy: the Johns Hopkins experience after 10 years. Urologic Clinics of North America, 20, 713-725.
56. Paulson, D. F. (1994) Impact of radical prostatectomy in the management of clinically localized prostate cancer: long term results. Journal of Urology, 152, 1826-1830.
57. Pisani, P., Parkin, D. M., & Ferlay, J. (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. International Journal of Cancer, 55, 891-903.
58. Prostate Cancer Trialists Collaborative Group (1995) Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. Lancet, 346, 265-269.
59. Rosen, M. A. (1995) Analysis of the annual cost of a fully implemented prostate cancer screening program. Journal of Urology, 153, suppl. 464A.
60. Ross, R. K., Bernstein, L., Judd, H., Hanisch, R., Pike, M. C. & Henderson, B. E. (1986) Serum testosterone levels in young black and white men. Journal of the National Cancer Institute, 76, 45-48.
61. Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E. & Henderson, B. E. (1995) Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer, 75, 1778-1782.
62. Ross, R. K., Henderson, B. E., Lobo, R. A., Shimuzu, H., Stanczyck, F., Puke, M. C. & Henderson, B. E. (1992) 5-α-reductase activity and risk of prostate cancer among Japanese and U.S. white and black males. Lancet, 339, 887-890.
63. Scardino, P. T., Beck, J. R. & Miles, B.J. (1994) Conservative management of prostate cancer. Editorial comment on Chodak, G. W. et al. New England Journal of Medicine, 330, 1831.
64. Schellhammer, P F., Whitmore, R. B., Kuban, D. A., El-Mahdi, A. M. & Ladaga, L. A.(1989) Morbidity and mortality of local failure after definitive therapy for prostate cancer. Journal of Urology, 141, 567-572.
65. Schroeder, F. H. (1993) Endocrine therapy for prostate cancer: recent developments and current status. British Journal of Urology, 71, 633-640.
66. Schroeder, F. H. (1995) Screening, early detection and treatment of prostate cancer: European view. Urology, 46 (Suppl. 3A), 62-70.
67. Schwartz, G. C. & Hulka, B. S (1990) Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis). Anticancer Research, 10, 1307-1311.
68. Seidell, J. C., Cigolini, M., Deslapere, J. P., Charzewska, J. & Ellsinger, B. M. (1991) Polyunsaturated fatty acids in adipose tissue in European men aged 38 years in relation to serum lipids, smoking habits, and fat distribution. American Journal of Epidemiology, 134, 583-589.
69. Sevanaian, A. & Peterson, A. R. (1984) Cholesterol epoxide, a product of in vivo cholesterol oxidation, is a direct acting mutagen. Procedings of the National Academy of Sciences, USA, 81, 4198-4202.
70. Skegg, D. C., Matthews, J. D., Guillebaud, J., Vessey, M. P., Biswas, S., Ferguson, K. M., Kitchin, Y., Mansfield, H. D. & Sommerville, I. F. (1976) Hormonal assessment before and after vasectomy. British Medical Journal, 1, 621-622.
71. Smith, P. H. (1995) Hormonal manipulation of metastatic prostate cancer. Current Opinion in Urology, 5, 243-245.
72. Soffen, E. M., Hanks, G. E., Hunt, M. A. & Epstein, B. E. (1992) Conformal static field radiation therapy treatment of early prostate cancer versus non-contbrmal techniques: a reduction in acute morbidity. International Journal of Radiation Oncology, Biology and Physics, 24, 485-488.
73. Soloway, M. S., Sharifi, R., Wajsman, Z., McLeod, D., Wood, D. P. Jr & Puras-Baez, A. (1995) Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2b Nx Mo) prostate cancer. Journal of urology, 154, 424-428.
74. Spitz, M. R., Currier, R. D., Fueger, J. J., Babaian, J. & Newell, G. R. (1991) Familial pattern of prostate cancer: a case-control analysis. Journal of Urology, 146, 1305-1307.
75. Sporer, A., Brill, D. R. & Schaffner, C. P. (1982) Epoxycholesterols in secretions and tissues of normal, benign and cancerous human prostatic glands. Urology, 20, 244-250.
76. Staszewski, W. & Haenszel, M. A. (1965) Cancer mortality among the Polish-born in the United States. Journal of the National Cancer Institute, 35, 291-297.
77. Steinberg, G. D., Carter, B. S., Beaty, T. H., Childs, B. & Walsh, P. (1990) Family history and the risk of prostate cancer. Prostate, 17, 337-347.
78. van der Gulden, J. W. J., Kolk, J. J. & Verbeek, A. L. M. (1994) Socioeconomic status, urbanization grade, and prostate cancer. Prostate, 25, 59-65.
79. Varma, M. M., Varma, R. R., Johanson, A. J., Kowarski, A. & Migeon, C. J. (1975) Long-term effects of vasectomy on pituitary-gonadal function in man. Journal of Clinical Endocrinology and Metabolism. 40, 868-871.
80. Wilt, T. J. & Brawer, M. K. (1995) The Prostate Cancer Intervention versus Observation Trial (PIVOT). Cancer, 75, 1963-1968.
81. Zagars, G. K. & Von Eschenbach, A. C. (1993) Prostate specific antigen: an important marker for prostate cancer treated by external beam radiation therapy. Cancer, 72, 538-548.
82. Zaridze, D. G., Boyle, P. & Smans, M. (1984) International trends in prostatic cancer. International Journal of Cancer, 33, 223-230.